Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Deloitte
Julphar
QuintilesIMS
AstraZeneca
Express Scripts
Merck
Dow
Teva
Medtronic
UBS

Generated: December 11, 2017

DrugPatentWatch Database Preview

Details for Patent: 7,947,017

« Back to Dashboard

Which drugs does patent 7,947,017 protect, and when does it expire?


Patent 7,947,017 protects AUVI-Q and EVZIO and is included in three NDAs.

This patent has one hundred patent family members in fourteen countries.

Summary for Patent: 7,947,017

Title:Devices, systems and methods for medicament delivery
Abstract: An apparatus includes a movable member and a valve coupled to the movable member. The movable member is configured to be disposed within a housing of a medical device and has a first end portion and second end portion. A portion of the first end portion is configured to define a portion of a boundary of a gas chamber. The first end portion defines an opening configured to be in fluid communication between the gas chamber and an area outside the gas chamber. The second end portion is configured to be coupled to a needle configured to deliver a medicament into a body. The valve is configured to selectively allow fluid communication between the gas chamber and the area outside the gas chamber through the opening defined by the first end portion of the movable member.
Inventor(s): Edwards; Evan Thomas (Fredericksburg, VA), Edwards; Eric Shawn (Midlothian, VA), Licata; Mark J. (Doswell, VA)
Assignee: Intelliject, Inc. (Richmond, VA)
Application Number:11/566,422
Patent Claim Types:
see list of patent claims
Composition; Device; Dosage form;

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Patented / Exclusive Use
Kaleo IncAUVI-QepinephrineINJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS201739-002Aug 10, 2012BXRXYesYes► Subscribe► Subscribe► SubscribeY
Kaleo IncAUVI-QepinephrineINJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS201739-001Aug 10, 2012BXRXYesNo► Subscribe► Subscribe► SubscribeY
Kaleo IncEVZIOnaloxone hydrochlorideSOLUTION;INTRAMUSCULAR, SUBCUTANEOUS205787-001Apr 3, 2014DISCNYesNo► Subscribe► Subscribe► SubscribeY
Kaleo IncEVZIOnaloxone hydrochlorideSOLUTION;INTRAMUSCULAR, SUBCUTANEOUS209862-001Oct 19, 2016RXYesYes► Subscribe► Subscribe► SubscribeY
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Non-Orange Book Patents for Patent: 7,947,017

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
8,425,462Devices, systems, and methods for medicament delivery► Subscribe
8,361,026Apparatus and methods for self-administration of vaccines and other medicaments► Subscribe
7,918,823Devices, systems and methods for medicament delivery► Subscribe
8,608,698Devices, systems and methods for medicament delivery► Subscribe
9,278,182Devices, systems and methods for medicament delivery► Subscribe
9,327,077Medical injector with compliance tracking and monitoring► Subscribe
8,231,573Medicament delivery device having an electronic circuit system► Subscribe
9,278,177Medical injector with compliance tracking and monitoring► Subscribe
9,259,539Devices, systems and methods for medicament delivery► Subscribe
8,172,082Devices, systems and methods for medicament delivery► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Patent: 7,947,017

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
United Kingdom2480407► Subscribe
United Kingdom201213906► Subscribe
United Kingdom2491283► Subscribe
Hong Kong1123758► Subscribe
Israel183247► Subscribe
Hong Kong1126992► Subscribe
China101111281► Subscribe
China101087625► Subscribe
Canada2926365► Subscribe
Canada2976873► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Mallinckrodt
Accenture
Julphar
Fish and Richardson
Cerilliant
Covington
US Army
Merck
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot